483 Eli Lilly and Company Dec 2013

483 Eli Lilly and Company Dec 2013

Joseph Strelnik FDA, Meisha Waters FDA, Meisha Sampson FDA$119.00 - Available Now

FDA investigators audited the Eli Lilly and Company - Indianapolis, IN, United States facility and issued inspectional observation (via FDA 483) on 06 Dec 2013.

Product details

  • Category: Human Drugs / Medical Devices & Rad Health
  • Inspection end: 06 Dec 2013
  • Location: Indianapolis, United States
  • FEI: 1819470
Add To Cart